Insmed (NASDAQ:INSM) Coverage Initiated at Jefferies Financial Group
Stock analysts at Jefferies Financial Group initiated coverage on shares of Insmed (NASDAQ:INSM – Get Free Report) in a report issued on Tuesday, MarketBeat reports. The brokerage set a “buy” rating and a $105.00 price target on the biopharmaceutical company’s stock. Jefferies Financial Group’s price target points to a potential upside of 60.04% from the […]
Stock analysts at Jefferies Financial Group initiated coverage on shares of Insmed (NASDAQ:INSM – Get Free Report) in a report issued on Tuesday, MarketBeat reports. The brokerage set a “buy” rating and a $105.00 price target on the biopharmaceutical company’s stock. Jefferies Financial Group’s price target points to a potential upside of 60.04% from the […]
